Informatie:
Fout:
ID
14286
Beschrijving
Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101); ODM derived from: https://clinicaltrials.gov/show/NCT00306163
Link
https://clinicaltrials.gov/show/NCT00306163
Trefwoorden
Versies (1)
- 07-04-16 07-04-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
7 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Asthma NCT00306163
Eligibility Asthma NCT00306163
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00306163
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
history of bronchial asthma
Item
history of bronchial asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
fev1 > 1.20 l
boolean
C0748133 (UMLS CUI [1])
positive skin prick test
Item
positive skin prick test
boolean
C0430561 (UMLS CUI [1])
fluticasone propionate
Item
not more than 500 mcg/day fluticasone propionate or equivalent for at least 28 days prior to baseline visit
boolean
C0117996 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
clinically relevant abnormal laboratory values
Item
clinically relevant abnormal laboratory values
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
Item
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
copd or other relevant lung diseases
Item
chronic obstructive pulmonary disease (copd) and /or other relevant lung diseases
boolean
C0024117 (UMLS CUI [1,1])
C0024115 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,2])
asthma exacerbation
Item
one asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
smoking history
Item
current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C1277691 (UMLS CUI [2])
saline challenge
Item
positive response to saline challenge at baseline visits
boolean
bronchial hyperresponsiveness
Item
positive bronchial hyperresponsiveness
boolean
C0085129 (UMLS CUI [1])